abstract |
The method of treating cancer comprises administering to a cancer patient an anti-CD38 antibody-damped human IFN alpha-2b construct and a lenalidomide or a fomalidomide. Tumors that can be treated in accordance with these methods are tumors that include CD-38 expressing tumor cells, including B-cell lymphoma, multiple myeloma, non-Hodgkin's lymphoma, chronic myelogenous leukemia, chronic lymphocytic leukemia, and acute lymphoblastic leukemia . |